Prostate Cancer News and Research

Latest Prostate Cancer News and Research

UT Southwestern researchers discover enzyme that promotes tumor growth

UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.

28 Nov 2018

Japan-India collaboration results in new treatment approach for male urethral stricture

A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six patients.

25 Nov 2018

Lower levels of protein make squamous carcinoma cells more invasive

Loss of a protein called TRIM29 promotes cancer cell invasion in a common type of skin cancer, suggesting a novel diagnostic marker and a possible therapeutic target.

21 Nov 2018

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR).

20 Nov 2018

Scientists equip new virus that kills carcinoma cells with protein

Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

19 Nov 2018

Report reveals increase in pancreatic cancer death rates across Europe

Pancreatic cancer death rates in the European Union have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU’s top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer.

15 Nov 2018

Study defines biomarker in response to treatment of castration-resistant prostate cancer

The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated with two different therapies: taxanes or hormone treatment. Until this day there are no comparative studies between the two and the decision on which treatment to use is done empirically and based on the patient's preferences.

14 Nov 2018

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate.

9 Nov 2018

Study uses gold nanoparticles to remove prostate cancer cells

A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is the first trial of its kind in the world.

9 Nov 2018

Prostate cancer patients receiving androgen deprivation therapy may have higher heart failure risk

Androgen deprivation therapy was associated with a 72 percent higher risk of heart failure in a study of patients with prostate cancer.

7 Nov 2018

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

The U.S. Department of Defense has granted the "Impact Award" to explore new therapeutic options against advanced prostate cancer - scientifically known as castration-resistant or hormone therapy resistant prostate cancer- to a multidisciplinary team of researchers made up of the Prostate Cancer Clinical Research Unit of the Spanish National Cancer Research Center, led by David Olmos, the Prostate Cancer Translational Research Group of the Vall d'Hebron Institute of Oncology, led by Joaquín Mateo, and the Genetics and Solid Tumors Laboratory of the University of Washington, led by Colin Pritchard.

7 Nov 2018

New synthetic compound based on brain hormone holds promise for cancer treatment

A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.

6 Nov 2018

Men with early prostate cancer choose lower survival odds to improve quality of life

Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival for improvements in side effects and quality of life, according to research presented at the 2018 NCRI Cancer Conference.

5 Nov 2018

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

Women with HER2-positive breast cancer that has spread to the brain need more treatment options, and City of Hope and Mustang Bio Inc. are meeting that challenge.

30 Oct 2018

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

Immunotherapy -- harnessing T-cells to attack cancer cells in the body -- has given hope to patients who endure round after round of treatment, including chemotherapy, to little effect. For all of its promise, however, immunotherapy still benefits only a minority of patients -- a reality driving research in the field for ways to improve the relatively new approach.

30 Oct 2018

Quantum dot-based FISH method enhances cell imaging

A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes.

30 Oct 2018

SBRT found to be safe treatment for patients with multiple metastases

The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy could be used safely in oligometastatic patients with multiple metastases.

24 Oct 2018

New type of molecule shows early promise against treatment-resistant prostate cancer

A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

23 Oct 2018

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

An interview with Dr.

From Huron Digital Pathology 23 Oct 2018

Radiotherapy combined with androgen-deprivation therapy improves overall survival up to 10 years

The long-term follow up of the NRG Oncology trial RTOG 9408, studying the addition of short-term androgen-deprivation therapy (ADT) to radiotherapy (RT) for men with early, localized prostate adenocarcinoma, indicated that RT combined with ADT is superior to RT alone for overall survival up to 10.4 years following treatment.

23 Oct 2018

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

UT Southwestern researchers discover enzyme that promotes tumor growth

Japan-India collaboration results in new treatment approach for male urethral stricture

Lower levels of protein make squamous carcinoma cells more invasive

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Scientists equip new virus that kills carcinoma cells with protein

Report reveals increase in pancreatic cancer death rates across Europe

Study defines biomarker in response to treatment of castration-resistant prostate cancer

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Study uses gold nanoparticles to remove prostate cancer cells

Prostate cancer patients receiving androgen deprivation therapy may have higher heart failure risk

U.S. Department of Defense grants 'Impact Award' to explore therapeutic options against advanced prostate cancer

New synthetic compound based on brain hormone holds promise for cancer treatment

Men with early prostate cancer choose lower survival odds to improve quality of life

New City of Hope CAR T cell trial focuses on HER2-positive breast cancer patients with brain metastases

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

Quantum dot-based FISH method enhances cell imaging

SBRT found to be safe treatment for patients with multiple metastases

New type of molecule shows early promise against treatment-resistant prostate cancer

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Radiotherapy combined with androgen-deprivation therapy improves overall survival up to 10 years

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in